Targeted therapy improves pregnancy outcomes

Amongst women who experience recurrent pregnancy loss, around 20% test positive for a specific antibody that targets the mother’s own body. A Kobe University-led research team now found a treatment that drastically increases these women’s chances of carrying to full-term without complications.

Rituximab biosimilar by Celltrion for Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma): Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

February 16, 2024

Fore! Amgen to become title sponsor of Irish Open

Amgen’s $28 billion Horizon Therapeutics takeover came with rare inflammatory disease medicines and, apparently, a tee time. The company will become title sponsor of the

December 15, 2023

Innovative imaging technique reveals structure of the thymus

The first 3D images of a whole human thymus have been created using a specialized X-ray technique by researchers from UCL and the Francis Crick

November 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.